GlassScriptPhysician profile
Mark Anthony Spicer
NPI 1619905684
$466.01
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $120 · 2021: $68.28 · 2023: $54.17 · 2024: $80.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $101.80 | 2021-2023 | Infinity Occipitocervical Upper Thoracic System |
| Stryker Corporation | $93.96 | 2019 | |
| Centinel Spine, LLC | $74.72 | 2020 | |
| Corcept Therapeutics | $46.22 | 2024 | Korlym |
| Medtronic USA, INC. | $33.27 | 2019 | |
| Acell, INC. | $27.16 | 2020 | |
| Nevro Corp. | $20.65 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.46 | 2024 | Xifaxan |
| Heraeus Medical, LLC. | $17.82 | 2020 | |
| Nuvasive, INC. | $16.18 | 2019 | |
| Integra Lifesciences Corporation | $15.77 | 2024 | Cusa Clarity, Duraseal Exact Spinal Sealant System, Codman Certas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Spicer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.